Navigation Links
Low Installation Rates in Retail Pharmacies Across Europe Increase the Growth Potential of the Pharmacy Automation Systems Market, Finds Frost & Sullivan
Date:9/1/2010

LONDON, Sept. 1 /PRNewswire/ -- The pharmacy automation systems market in Europe is experiencing a tremendous growth spurt. Until recently, most pharmacies have been either without automation or have employed very basic automation systems. In response, the adoption rate of automation systems across Europe has been progressing from basic prescription management systems to advanced medication pick-up and drug dispensing automation systems. Likewise, although the adoption of automation systems has been most prevalent among hospital pharmacies, there is significant potential for growth in the retail pharmacy market across Europe.

(Logo: http://photos.prnewswire.com/prnh/20081117/FSLOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

New analysis from Frost & Sullivan (http://www.healthcareIT.frost.com), European Markets for Pharmacy Automation Systems, finds that the market earned revenues of $151.4 million in 2009 and estimates this to reach $360.2 million by 2016. This research service particularly focuses on prescription management automation systems, medication pick-up automation systems and drug dispensing automation systems.

"Pharmacy automation systems translate a product-centric pharmacy model into a patient-centric workflow model, thus improving the pharmacy environment for both the patients and the pharmacists," says Frost & Sullivan Industry Analyst S. Priyan. "More importantly, these systems reduce the waiting time for the patients, lower medication errors, prevent adverse drug events (ADE), and ease operating costs for the pharmacy, thereby enhancing patient safety, pharmacy productivity, and turnover."

There is considerable demand and potential for automation systems among retail pharmacies. Although the annual maintenance charges of automation systems are one of the least in the healthcare IT market in Europe, the revenues of pharmacy automation systems market are expected to more than double only by 2016.

However, diverse adoption characteristics among the various pharmacy groups in Europe result in slow market growth. Furthermore, the availability of varied information systems in the market for pharmacy workflows tends to confuse the end users, resulting in reduced penetration rates.

"There are several information systems available for pharmacy deployment in Europe such as pharmacy management systems, pharmacy information systems, and electronic prescribing systems," explains Priyan. "These systems reduce the market potential for advanced pharmacy automation systems as the end users make do with these basic workflow automation systems to meet the automation requirements of their pharmacy."

Standardising and consolidating delivery models for various pharmacy groups will help in increasing penetration rates. Organising workshops designed to educate end users on the systems' capabilities, and convening meetings to understand their requirements for offering customised solutions, will promote customer satisfaction, and thereby expand the customer base.

If you are interested in more information on this study, please send an e-mail to Katja Feick, Corporate Communications, at katja.feick@frost.com, with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country.

European Markets for Pharmacy Automation Systems is part of the Healthcare & Life Sciences IT Growth Partnership Services programme, which also includes research in the following markets: European Markets for Business Analytics in Healthcare, Electronic Medical Records Market in Europe, and Strategic Analysis of Care Management Market in Europe. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

About Frost & SullivanFrost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.European Markets for Pharmacy Automation Systems (M567)Contact:Katja FeickCorporate Communications – EuropeP: +49 (0) 69 7703343E: katja.feick@frost.comhttp://www.frost.comTwitter: twitter.com/frost_sullivan
'/>"/>

SOURCE Frost & Sullivan
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New TROY SecureRx Prescription Printer Marks 50th Hospital Installation Milestone
2. Heska Announces First Installation of New Blood Gas & Electrolyte Analyzer
3. Health Robotics Surpasses 100 Installations Milestone and Acquires Two I.V. Room of the Future Partner Companies
4. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
5. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
6. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
7. GlaxoSmithKline Accelerates Review of Exelixis XL880
8. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
9. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
10. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
11. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... 2016 At the Sachs CEO ... a Phase 2 clinical study of its lead drug ... cochlear implantation (CI) surgery. This large, placebo-controlled, double-blind, phase ... Germany and France . ... the time of surgery. "Despite advances in cochlear implant ...
(Date:4/26/2016)... , April 26, 2016 Hill-Rom Holdings, Inc. ... a management presentation at the Deutsche Bank 41 st ... 2:50 p.m. EDT. You are invited to listen ... http://ir.hill-rom.com/events.cfm or access it directly at http://edge.media-server.com/m/p/mr4uxgas . ... hour after conclusion of the live event and accessible at ...
(Date:4/26/2016)... April 27, 2016 Research and ... Molecular Diagnostics Market 2016-2020" report to their offering. ... ,The global molecular diagnostics market is projected to grow ... Molecular diagnostics is a technique that involves ... molecular level to detect changes in biochemical pathways. The ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... 29, 2016 , ... Our bodies are bombarded daily by environmental and lifestyle ... these stressors is to adopt a more healthful diet, but too many people think ... certified Holistic Nutritionist and the creator of the Newport Beach Cleanse and 14-Day Eating ...
(Date:4/29/2016)... ... April 29, 2016 , ... The White House ... their loans, more information about their loan terms and accounts, and more protections ... debt, including federal and private loans, has reached $1.3 trillion, with 43 million ...
(Date:4/29/2016)... ... ... Spine Team Texas, a comprehensive spine physician group specializing in the treatment of ... invited to be a featured speaker at the Texas Society of the American College ... , Dr. R. Scott McPherson, a physical medicine and rehabilitation specialist, will speak ...
(Date:4/29/2016)... ... 29, 2016 , ... The Gluten-Free Certification Program (GFCP), in ... the launch of the GFCP Scoop in response to consumer demand ... the GFCP Scoop site is to keep the gluten-free community updated ...
(Date:4/29/2016)... Beverly Hills, CA (PRWEB) , ... April 29, 2016 , ... ... distributor of devices and products for the head and neck/ear, nose and throat specialty, ... Safety Device , The KOTLER NASAL AIRWAY™ is a newly patented safety ...
Breaking Medicine News(10 mins):